Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone.

Biomaterials
C KubiakB Clausse

Abstract

The cytotoxicities of free cyanoacrylic nanoparticles, free Adriamycin, Adriamycin-loaded nanoparticles and a mixture of Adriamycin and nanoparticles are compared in cancer cell cultures. Increased cytotoxicity was observed in the sensitive (DC3F) subline when Adriamycin was in particulate form rather than free. In the derived pleiotropic resistant subline (DC3F AD/AZA), sensitivity to Adriamycin was completely restored with the conjugate. Addition of verapamil or amiodarone allowed an enhancement of efficiency of tenfold for free Adriamycin and between two- and fourfold for its conjugate form. Vectorization by nanoparticles and pharmacological modulation of cell membrane can act in synergy in synergy to overcome the resistance to Adriamycin in vitro.

Citations

Mar 23, 1999·Pharmaceutica acta Helvetiae·S NagaichN K Jain
Sep 3, 2002·Advanced Drug Delivery Reviews·Irène BriggerPatrick Couvreur
Apr 23, 2003·Advanced Drug Delivery Reviews·Christine VauthierPatrick Couvreur
Jan 9, 2009·The Journal of Biological Chemistry·Linda HasadsriJulia M George
Jul 11, 1998·Journal of Biomaterials Science. Polymer Edition·R Yoda
Sep 18, 2014·International Journal of Environmental Research and Public Health·Davide LovisoloFederico Alessandro Ruffinatti
Aug 10, 2010·The Journal of Surgical Research·Paola LosiGiorgio Soldani
Mar 29, 2007·ANZ Journal of Surgery·Peter A LeggatUreporn Kedjarune
May 23, 2018·Biomaterials Science·Jay M Korde, Balasubramanian Kandasubramanian
Feb 6, 2019·Journal of Drug Targeting·Simona MuraJulien Nicolas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.